US FDA Advisors Urge Faster Movement, mRNA Consideration, In Updating Pandemic Flu Vaccines

The FDA’s vaccine advisory committee endorsed a new plan to update pandemic influenza vaccines “inter-pandemic,” but encouraged the agency to consider how to make the approach feasible for novel vaccine technologies.